## **Core Concept**
Anti-Hu paraneoplastic neuropathy, also known as **sensory neuronopathy**, is a type of paraneoplastic neurological disorder (PND) associated with **small cell lung cancer (SCLC)** and other neuroendocrine tumors. It primarily affects the sensory neurons, leading to a range of neurological symptoms.

## **Why the Correct Answer is Right**
The correct answer, **sensory predominant neuropathy**, is right because anti-Hu antibodies target the **Hu proteins** which are predominantly expressed in sensory neurons. This autoimmune response results in **degeneration of sensory neurons**, leading to symptoms such as **dysesthesia**, **pain**, **numbness**, and **loss of proprioception**. The sensory predominant neuropathy is a hallmark of this condition, distinguishing it from other forms of neuropathy.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is incorrect because while autonomic neuropathy can be a component of some paraneoplastic syndromes, it is not the primary manifestation of anti-Hu neuropathy.
- **Option B:** This option is incorrect as motor predominant neuropathy is not characteristic of anti-Hu paraneoplastic neuropathy; the condition primarily affects sensory neurons.
- **Option D:** This option is incorrect because, although autonomic dysfunction can occur in the context of various neuropathies, it is not the defining feature of anti-Hu paraneoplastic neuropathy.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that **anti-Hu neuropathy often precedes the diagnosis of the underlying tumor**, such as small cell lung cancer. Therefore, in patients presenting with a **rapidly progressive sensory neuropathy**, especially with **pain and sensory ataxia**, it is crucial to investigate for underlying malignancy.

## **Correct Answer:** . Sensory predominant neuropathy